These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 16465756)

  • 21. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Step management of hypercholesterolemia.
    Repka FJ; Leighton RF
    Am Fam Physician; 1987 Oct; 36(4):238-48. PubMed ID: 3314439
    [No Abstract]   [Full Text] [Related]  

  • 23. [Commentary: External validity of studies on Primary Care prevention of Hypercholesterolemia].
    Brotons C
    Aten Primaria; 2003 Nov; 32(9):514-6. PubMed ID: 14651828
    [No Abstract]   [Full Text] [Related]  

  • 24. Applying the new cholesterol guidelines to your practice.
    Geisler SL
    JAAPA; 2001 Nov; 14(11):12-4, 17-8, 21-3. PubMed ID: 11766422
    [No Abstract]   [Full Text] [Related]  

  • 25. High cholesterol levels in healthy seniors: cause for concern?
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(1):40-1. PubMed ID: 7770441
    [No Abstract]   [Full Text] [Related]  

  • 26. [The 10-minute consultation: accidently discovered hypercholesteremia].
    Tatò F
    MMW Fortschr Med; 2004 Sep; 146(35-36):59-60. PubMed ID: 15540545
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
    Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
    Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical inquiries. What levels of cholesterol should be treated for primary prevention?
    Seaton TL; Meadows S
    J Fam Pract; 2002 May; 51(5):423. PubMed ID: 12019047
    [No Abstract]   [Full Text] [Related]  

  • 29. Summary of the third report of the National Cholesterol Education Program Adult Treatment Panel III.
    Lepor NE; Vogel RE;
    Rev Cardiovasc Med; 2001; 2(3):160-5. PubMed ID: 12439378
    [No Abstract]   [Full Text] [Related]  

  • 30. Toward better therapy of hypercholesterolemia.
    Laubach E; Otto C; Schwandt P
    Arch Intern Med; 2000 Sep; 160(17):2685-6. PubMed ID: 10999996
    [No Abstract]   [Full Text] [Related]  

  • 31. [2 limits of serum cholesterol levels are appropriate in the diagnosis and treatment of hypercholesterolemia].
    Walldius G; Jungner I
    Lakartidningen; 1988 Nov; 85(45):3835-9. PubMed ID: 3185048
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lowering cholesterolemia in the prevention of coronary diseases. (Part 2). Canadian work group on the periodic medical examination].
    Union Med Can; 1994 May; 123(5):312-26. PubMed ID: 8036729
    [No Abstract]   [Full Text] [Related]  

  • 33. Outcomes of a worksite cholesterol education program over a 5-year period.
    Perovich SJ; Sandoval WM
    J Am Diet Assoc; 1995 May; 95(5):589-90. PubMed ID: 7722197
    [No Abstract]   [Full Text] [Related]  

  • 34. The cholesterol challenge: from laboratory to clinician.
    Naito HK
    Clin Chem; 1988 Feb; 34(2):444-9. PubMed ID: 3342535
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cholesterol and coronaropathy].
    Vergani C
    G Ital Cardiol; 1993 Mar; 23(3):221-4. PubMed ID: 8325457
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia.
    Junyent M; Cofán M; Núñez I; Gilabert R; Zambón D; Ros E
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1107-13. PubMed ID: 16556855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
    MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
    [No Abstract]   [Full Text] [Related]  

  • 38. [Realization of the project of metabolic out-patient care in men with hypercholesterolemia according to the program of primary prevention of coronary disease (author's transl)].
    Kocemba J; Kawecka-Jaszcz K; Magdoń M
    Przegl Lek; 1977; 34(8):661-4. PubMed ID: 928815
    [No Abstract]   [Full Text] [Related]  

  • 39. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The decision to treat based on epidemiological methodology: the paradigm of hypercholesterolemia].
    Kornitzer M
    Rev Med Brux; 1999 Jun; 20(3):135-41. PubMed ID: 10429536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.